Self-Assembled Lenalidomide/AIE Prodrug Nanobomb for Tumor Imaging and Cancer Therapy

Zhijian Mai,Nengjie Cao,Erzhuo Cheng,Zhiwen Zeng,Yancong Feng,Yao Wang,Paddy J. French,Yi-Kuen Lee,Haihong Yang,Bin Yang,Hao Li,Guofu Zhou
DOI: https://doi.org/10.1021/acsanm.3c03611
IF: 6.14
2023-01-01
ACS Applied Nano Materials
Abstract:To develop multifunctional small-molecule prodrugs is highly desirable for cancer treatment but remains challenging in intrinsic traceability. As an acid-cleavable linkage, a Schiff bases benefiting from its distinctive fluorescence quenching ability was selected to prepare a small-molecule prodrug with cancer-targeted and self-indicating. In this study, we designed and developed a multifunctional self-assembled nanobomb of amphiphilic TPE-Lenalidomide prodrug, which comprises a hydrophobic aggregation-induced emission (AIE) probe 4-(1,2,2-triphenylvinyl)benzaldehyde (TPE-CHO) and a hydrophilic anticancer drug Lenalidomide via a Schiff base linkage. We investigated the synergistic effect of d-PET and C=N isomerization which would keep the fluorescence of TPE-Lenalidomide in the "always off" state by density functional theory (DFT) calculation. Once reaching the pathological site, such a vesicular nanobomb of TPE-Lenalidomide will be acidolyzed to release the AIE probe and Lenalidomide molecules simultaneously, consequently realizing high-efficiency effects of tumor imaging and cancer therapy (cell viability: normal cell L929, similar to 79.49%; cancer cell 4T1, similar to 27.08%; p = 0.000118). This work may pave an avenue to prepare small-molecule prodrugs for tumor-targeted diagnosis and cancer therapy.
What problem does this paper attempt to address?